The Expanding Role of Fluid Biomarkers in the Diagnosis and Management of Patients With Alzheimer Disease
The Expanding Role of Fluid Biomarkers in the Diagnosis and Management of Patients With Alzheimer Disease is organized by Physicians' Education Resource, LLC (PER).
Release Date: April 27, 2023
Expiration Date: April 27, 2024
Description:
A variety of proteins related to various aspects of Alzheimer disease (AD) pathophysiology have been suggested as biomarkers for the condition. Cerebrospinal fluid biomarkers reflect the 3 well-established hallmarks of AD. This symposium features experts reviewing state-of-the-science on the role of new and emerging fluid biomarkers in AD.
This educational activity is an archive of the live virtual symposium held on March 4, 2023.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Identify the role of fluid biomarkers in the diagnosis of Alzheimer disease
• Assess clinical trial data for the fluid biomarkers currently available for the diagnosis of Alzheimer disease
• Integrate fluid biomarkers into management plans for patients with suspected Alzheimer disease.